Anders Lennart Tullgren
Chairman presso XBRANE BIOPHARMA AB
Patrimonio netto: 17 533 $ in data 31/03/2024
Profilo
Anders Lennart Tullgren is the founder of Tullgren Consulting Ltd.
He currently holds the position of Chairman at BerGenBio ASA since 2022, Chairman at Xbrane Biopharma AB since 2018, Chairman at Branding Science UK Ltd.
since 2017, Director at Norgine Pharma, Director at Branding Science Group Ltd.
since 2017, and Advisor at DRI Capital, Inc. Additionally, he has previously served as Chairman at Dizlin Pharmaceuticals AB, Director at Trialbee AB from 2018 to 2019, Independent Director at Biotoscana Investments SA, and President-Intercontinental Region at Bristol-Myers Squibb GmbH & Co. KGaA from 2010 to 2017.
Mr. Tullgren obtained a graduate degree from the University of Uppsala.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0.04% | 31/12/2022 | 621 734 ( 0.04% ) | 17 533 $ | 31/03/2024 |
Posizioni attive di Anders Lennart Tullgren
| Società | Posizione | Inizio |
|---|---|---|
| XBRANE BIOPHARMA AB | Chairman | 03/04/2018 |
| BERGENBIO ASA | Chairman | 06/01/2022 |
Branding Science UK Ltd.
 Branding Science UK Ltd. Miscellaneous Commercial ServicesCommercial Services Branding Science UK Ltd. provides market research services. The private company is based in London, UK. | Chairman | - |
Branding Science Group Ltd.
 Branding Science Group Ltd. Miscellaneous Commercial ServicesCommercial Services Branding Science Group Ltd. is a British company that provides market research and consulting services for the pharmaceutical industry. The private company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2012. | Director/Board Member | 01/10/2017 |
| Tullgren Consulting Ltd. | Founder | - |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | - |
Norgine Pharma
 Norgine Pharma Pharmaceuticals: MajorHealth Technology Norgine Pharma manufactures pharmaceutical product. It offers medicines, vaccines, tablets and injection. The company is headquartered in Dreux, France. | Director/Board Member | - |
Precedenti posizioni note di Anders Lennart Tullgren
| Società | Posizione | Fine |
|---|---|---|
Trialbee AB
 Trialbee AB Packaged SoftwareTechnology Services Trialbee AB provides software solutions and services to the pharmaceutical industry. It operates as a software company which specializes in clinical trial planning and management solutions. The firm offers global pharmaceutical companies and web-based solution for patient recruitment to clinical trials. The company was founded by Carl Johan Tobias Folkesson and Per Jonas Billing in October 2010 and is headquartered in Malmo, Sweden. | Chairman | 01/09/2018 |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Corporate Officer/Principal | 01/06/2017 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Anders Lennart Tullgren
| University of Uppsala | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BERGENBIO ASA | Health Technology |
| XBRANE BIOPHARMA AB | Health Technology |
| Aziende private | 9 |
|---|---|
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Norgine Pharma
Norgine Pharma Pharmaceuticals: MajorHealth Technology Norgine Pharma manufactures pharmaceutical product. It offers medicines, vaccines, tablets and injection. The company is headquartered in Dreux, France. | Health Technology |
Trialbee AB
Trialbee AB Packaged SoftwareTechnology Services Trialbee AB provides software solutions and services to the pharmaceutical industry. It operates as a software company which specializes in clinical trial planning and management solutions. The firm offers global pharmaceutical companies and web-based solution for patient recruitment to clinical trials. The company was founded by Carl Johan Tobias Folkesson and Per Jonas Billing in October 2010 and is headquartered in Malmo, Sweden. | Technology Services |
Biotoscana Investments SA
 Biotoscana Investments SA Pharmaceuticals: MajorHealth Technology Biotoscana Investments SA operates as a holding company, which engages in the development, manufacturing and commercialization of advanced medicine. Its operations include oncology, onco-hematology, severe infectious diseases, genetic and rare conditions as well as immunology and inflammation. The company was founded in August 16, 2011 and is headquartered in Montevideo, Uruguay. | Health Technology |
Branding Science UK Ltd.
Branding Science UK Ltd. Miscellaneous Commercial ServicesCommercial Services Branding Science UK Ltd. provides market research services. The private company is based in London, UK. | Commercial Services |
| Dizlin Pharmaceuticals AB | |
Branding Science Group Ltd.
Branding Science Group Ltd. Miscellaneous Commercial ServicesCommercial Services Branding Science Group Ltd. is a British company that provides market research and consulting services for the pharmaceutical industry. The private company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2012. | Commercial Services |
| Tullgren Consulting Ltd. | |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
- Borsa valori
- Insiders
- Anders Lennart Tullgren
